Physician profile
Luis E Vazquez
NPI 1083989719
$7,098.19
in general payments reported to CMS, 2019-2025
10 companies · $1,634 in 2025
The $1,634 reported for 2025 was more than what 86% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $185 · 2020: $2,572 · 2021: $1,146 · 2022: $1,134 · 2023: $228 · 2024: $199 · 2025: $1,634.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,140 · Food and Beverage: $921.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,140.00 |
| Food and Beverage | $921.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| New World Medical,INC. | $4,588.98 | 2020-2025 | Streamline, Kahook Dual Blade, Ahmed Glaucoma Valve |
| W. L. Gore & Associates, INC. | $1,140.00 | 2025 | Product In Development |
| Aerie Pharmaceuticals, INC. | $328.19 | 2019-2021 | |
| Alcon Vision LLC | $283.93 | 2021-2025 | Clareon, Clareon Panoptix Pro |
| Allergan, INC. | $258.84 | 2020-2022 | |
| Bausch & Lomb Americas INC. | $204.21 | 2025 | Miebo, Xiidra, Stellaris |
| Sight Sciences, INC. | $114.52 | 2023 | Omni Surgical System |
| Abbvie INC. | $113.63 | 2023 | Xen Glaucoma Treatment System |
| Johnson & Johnson Surgical Vision, INC. | $40.64 | 2021 | |
| Glaukos Corporation | $25.25 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Vazquez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.